13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001789778
Total reported value
$158.8M
$158.8M
9 檔
78.1%
The Q4 2025 SEC filing reveals that Blue Water Life Science Advisors, LP held a total portfolio value of $158.8M, covering 9 public equity positions.
In Q4 2025, Blue Water Life Science Advisors, LP displayed an active expansion posture, initiating 2 new positions and adding to 2 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GH | Guardant Health Inc | Stock-Healthcare | 22.76% | -7.10% | -12.47% | |
| 2 | NTRA | Natera Inc | Stock-Healthcare | 20.34% | -1.28% | — | |
| 3 | ADPT | Adaptive Biotechnologies | Stock-Other | 17.99% | +2.41% | -17.71% | |
| 4 | PSNL | Personalis Inc | Stock-Other | 8.37% | +5.59% | — | |
| 5 | QTRX | Quanterix CORP | Stock-Other | 8.35% | +3.40% | +118.44% | |
| 6 | TWST | Twist Bioscience CORP | Stock-Other | 7.63% | -10.52% | EXIT | |
| 7 | CDNA | Caredx Inc | Stock-Other | 6.03% | +8.34% | — | |
| 8 | GRAL | Grail Inc | Stock-Healthcare | 5.32% | — | — | |
| 9 | TEM | Tempus Ai Inc-cl A | Stock-Healthcare | 3.20% | -1.82% | +19.33% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | QTRX | Quanterix CORP | +3.6% | +118.44% | Add |
| 2 | GH | Guardant Health Inc | -0.4% | -12.47% | Trim |
| 3 | NTRA | Natera Inc | -0.4% | — | Unchanged |
| 4 | CDNA | Caredx Inc | -0.7% | — | Unchanged |
| 5 | PSNL | Personalis Inc | -1.6% | — | Unchanged |
| 6 | TEM | Tempus Ai Inc-cl A | -2.1% | +19.33% | Add |
| 7 | ADPT | Adaptive Biotechnologies | -11.3% | -17.71% | Trim |
| 8 | TWST | Twist Bioscience CORP | — | NEW | New buy |
| 9 | GRAL | Grail Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Blue Water Life Science Advisors, LP reported a total U.S. public equity portfolio value of $158.8M across 9 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including GH, NTRA, ADPT) accounted for 78.1% of total reported equity market value during Q4 2025.
Top New Position Initiated
TWST
市值: $12.1M
Top Position Liquidated / Trimmed
ADPT
前期市值: $32.1M
During Q4 2025, Blue Water Life Science Advisors, LP's top holdings by market value included GH (22.8%)、NTRA (20.3%)、ADPT (18.0%). The largest single position, GH, represented 22.8% of total portfolio value.
In Q4 2025, Blue Water Life Science Advisors, LP made 6 total portfolio adjustments, initiating 2 new buys, adding to 2 positions, trimming 2 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.